常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
47.50/--
|
|
企業價值
443.94K
|
| 資產負債 |
|
每股賬面淨值
12.38
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
699.00K
|
|
每股收益
0.65
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasivebladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers. |

0.4561 
